The idea of mRNA therapy was conceived decades before it became a reality during the COVID-19 pandemic. Today, mRNA vaccines have emerged as a powerful tool against new viral infections, mainly due to their versatility …
Read More
When Ephraim Tsalik transitioned from academia to Danaher, he had the chance to combine his infectious disease expertise with teams across various Danaher operating companies. His work aims to accelerate medical product advancement and bring …
Read More
From manufacturing oligonucleotides to keeping new product introduction teams aligned, to validating new facilities, to leading blue-sky innovations, Carla McDowell-Buchanan has worn an exceptional number of hats during her 14 years at Cepheid. Below, she …
Read More
Carla McDowell-Buchanan
